ES557739A0 - Un procedimiento para preparar un material peptidico que tiene actividad humoral timica - Google Patents

Un procedimiento para preparar un material peptidico que tiene actividad humoral timica

Info

Publication number
ES557739A0
ES557739A0 ES557739A ES557739A ES557739A0 ES 557739 A0 ES557739 A0 ES 557739A0 ES 557739 A ES557739 A ES 557739A ES 557739 A ES557739 A ES 557739A ES 557739 A0 ES557739 A0 ES 557739A0
Authority
ES
Spain
Prior art keywords
leu
timica
prepare
procedure
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557739A
Other languages
English (en)
Other versions
ES8801317A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of ES557739A0 publication Critical patent/ES557739A0/es
Publication of ES8801317A1 publication Critical patent/ES8801317A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/065Thymic humoral factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/18Thymus derived hormone or factor; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES557739A 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica Expired ES8801317A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/741,753 US4621135A (en) 1983-12-08 1985-06-06 Novel THF compositions

Publications (2)

Publication Number Publication Date
ES557739A0 true ES557739A0 (es) 1988-01-01
ES8801317A1 ES8801317A1 (es) 1988-01-01

Family

ID=24982034

Family Applications (6)

Application Number Title Priority Date Filing Date
ES555737A Expired ES8801322A1 (es) 1985-06-06 1986-06-05 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ES557740A Expired ES8801308A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ES557737A Expired ES8801307A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ES557739A Expired ES8801317A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ES557738A Expired ES8801316A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ES557736A Expired ES8801315A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES555737A Expired ES8801322A1 (es) 1985-06-06 1986-06-05 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ES557740A Expired ES8801308A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ES557737A Expired ES8801307A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557738A Expired ES8801316A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ES557736A Expired ES8801315A1 (es) 1985-06-06 1987-09-16 Un procedimiento para preparar un material peptidico que tiene actividad humoral timica

Country Status (16)

Country Link
US (1) US4621135A (es)
EP (1) EP0204328B1 (es)
JP (2) JPS6248698A (es)
KR (1) KR900003095B1 (es)
AT (1) ATE110389T1 (es)
AU (1) AU569193B2 (es)
CA (1) CA1270597A (es)
CZ (1) CZ419491A3 (es)
DE (2) DE3650035T2 (es)
DK (1) DK262986A (es)
ES (6) ES8801322A1 (es)
HK (1) HK195495A (es)
IL (1) IL78951A (es)
NZ (1) NZ216316A (es)
SK (1) SK419491A3 (es)
ZA (1) ZA863848B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
MX339762B (es) * 2011-09-28 2016-05-27 Univ Autonoma Del Estado De Morelos Metalopeptidos inmunomoduladores (immp) y composiciones que los contienen.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4881838A (es) * 1972-02-15 1973-11-01
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
SE448605B (sv) * 1980-10-27 1987-03-09 Vtoroi Mo G Med I Imen Terapeutiskt preparat for reglering av t-immunsystemet och forfarande for framstellning derav
US4374828A (en) * 1980-11-17 1983-02-22 Board Of Reagents, The University Of Texas System Biologically active thymones from the thymus
IT1148005B (it) * 1981-04-09 1986-11-26 Leonida Grippa Tripeptide nelle sue sei combinazioni amminoacide alania fenilalanina e leucina in particolare fenil-alanina-alanina-leucina (p-a-l) aventela proprieta' di esaltare l'immunita' antivirale ed antitumorale
US4505898A (en) * 1982-04-21 1985-03-19 Marks Robert E Derivatives of acetylsalicylic acid and substituted phenylacetic acids and compositions containing them

Also Published As

Publication number Publication date
ES8801322A1 (es) 1987-12-16
HK195495A (en) 1996-01-05
AU5833686A (en) 1987-01-08
ES8801316A1 (es) 1987-12-16
ES8801307A1 (es) 1987-12-16
DE3650035D1 (de) 1994-09-29
ES557736A0 (es) 1987-12-16
CZ419491A3 (en) 1993-03-17
ES557738A0 (es) 1987-12-16
KR900003095B1 (ko) 1990-05-07
SK419491A3 (en) 1995-07-11
DE3650035T2 (de) 1995-03-23
EP0204328A2 (en) 1986-12-10
IL78951A0 (en) 1986-09-30
CA1270597A (en) 1990-06-19
ES557740A0 (es) 1987-12-16
JPH01156997A (ja) 1989-06-20
JPH0422919B2 (es) 1992-04-20
JPS6248698A (ja) 1987-03-03
DK262986A (da) 1986-12-07
ATE110389T1 (de) 1994-09-15
ES8801308A1 (es) 1987-12-16
IL78951A (en) 1990-11-05
DE204328T1 (de) 1987-11-05
EP0204328A3 (en) 1988-07-27
AU569193B2 (en) 1988-01-21
ES557737A0 (es) 1987-12-16
ZA863848B (en) 1987-12-30
DK262986D0 (da) 1986-06-04
ES555737A0 (es) 1987-12-16
NZ216316A (en) 1991-11-26
JPH0210160B2 (es) 1990-03-06
US4621135A (en) 1986-11-04
ES8801315A1 (es) 1987-12-16
ES8801317A1 (es) 1988-01-01
EP0204328B1 (en) 1994-08-24
KR870000357A (ko) 1987-02-18

Similar Documents

Publication Publication Date Title
ATE78042T1 (de) Analoge des humanen relaxins.
NO905638L (no) Ledersekvens som induserer en post-translasjonell modifikasjon av polypeptider i bakterier og gen derav.
NO940299D0 (no) peptid med organbestkyttende aktivitet
ES557740A0 (es) Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
PT79088B (en) The synthesis of cyclopropane amino acids and peptides
AR009600A1 (es) Secuencia de acido nucleico y aminoacidos relacionados con helicobacter pylori y composiciones de vacuna de la misma.
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
ATE78872T1 (de) Herstellung von polypeptiden.
ATE81134T1 (de) Peptide.
DK1612555T3 (da) Kryptiske peptider til anvendelse til at inducere immunologisk tolerance
ATE79651T1 (de) Rekombinante materialien und verfahren zur herstellung von menschliche konnektive gewebe aktivierende peptide iii und deren analoge.